Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation

Molecular Endocrinology

Volumn 9, Issue 12, 1995, Pages 1804-1813

  Watts, Colin K W ^a   Brady, Andrea ^a   Sarcevic, Boris ^a   deFazio, Anna ^a   Musgrove, Elizabeth A ^a   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; FULVESTRANT; RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CELL CYCLE; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

BREAST NEOPLASMS; CELL CYCLE; CYCLIN D1; CYCLIN-DEPENDENT KINASES; CYCLINS; ESTRADIOL; ESTROGEN ANTAGONISTS; GENE EXPRESSION; HUMAN; ONCOGENE PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0028786916     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/mend.9.12.8614416     Document Type: Article

References (61)

1. Wakeling AE, Newboult E, Peters SW 1989 Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells. J Mol Endocrinol 2: 225-234
2. Musgrove EA, Wakeling AE, Sutherland RL 1989 Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. Cancer Res 49: 2398-2404
3. Sutherland RL, Hall RE, Taylor IW 1983 Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res 43: 3998-4006
4. Sutherland RL, Green MD, Hall RE, Reddel RR, Taylor IW 1983 Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle. Eur J Cancer Clin Oncol 19: 615-621
5. Osborne CK, Boldt DH, Clark GM, Trent JM 1983 Effects of tamoxifen on human breast cancer cell cycle kinetics: Accumulation of cells in early G1 phase. Cancer Res 43: 3583-3585
6. Taylor IW, Hodson PJ, Green MD, Sutherland RL 1983 Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res 43: 4007-4010
7. Lippman M, Bolan G, Huff K 1976 The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long term tissue culture. Cancer Res 36: 4595-4601
8. Osborne CK, Boldt DH, Estrada P 1984 Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. Cancer Res 44: 1433-1439
9. Sherr CJ 1993 Mammalian G, cyclins. Cell 73: 1059-1065
10. Morgan DO 1994 Principles of CDK regulation. Nature 374: 131-134
11. Hunt T, Sherr CJ 1994 Checks and balances. Curr Opin Cell Biol 6: 833-835
12. Hunter T, Pines J 1991 Cyclins and cancer. Cell 66: 1071-1074
13. Nurse P 1990 Universal control mechanism regulating onset of M-phase. Nature 344: 503-508
14. Musgrove EA, Hamilton JA, Lee CSL, Sweeney KJE, Watts CKW, Sutherland RL 1993 Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13: 3577-3587
15. Pines J 1993 Cyclins and cyclin-dependent kinases: Take your partners. Trends Biol Sci 18: 195-197
16. Lew DJ, Dulic V, Reed SI 1991 Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66: 1197-1206
17. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman J, Kronenberg H, Arnold A 1991 A novel cyclin encoded by a faci-linked candidate oncogene. Nature 350: 512-515
18. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ 1991 Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713
19. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G 1993 Cyclin D1 is a nuclear protein required for cell cycle progression in Gv Genes Dev 7: 812-821
20. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J 1994 Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57: 353-361
21. Musgrove EA, Lee CSL, Buckley MF, Sutherland RL 1994 Cyclin D1 induction in breast cancer cells shortens G! and is sufficient for cells arrested in Gi to complete the cell cycle. Proc Natl Acad Sci USA 91: 8022-8026
22. Watts CKW, Sweeney KJE, Warlters A, Musgrove EA, Sutherland RL 1994 Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Cancer Res Treat 31: 95-105
23. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J 1994 Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66
24. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D 1993 p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704
25. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ 1993 The p21 Cdk-interacting protein Cip1 is a potent inhibitor of Gn cyclin dependent kinases. Cell 75: 805-816
26. Sherr CJ 1994 G1 phase progression: Cycling on cue. Cell 79: 551-555
27. Tam SW, Theodoras AM, Shay JW, Draetta GF, Pagano M 1994 Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: Association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9: 2663-2674
28. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J-Y 1994 D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14: 2066-2076
29. Xiong Y, Zhang H, Beach D 1992 D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 505-514
30. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM 1992 Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689-1694
31. Dulic V, Lees E, Reed SI 1992 Association of human cyclin E with a periodic Gt-S phase protein kinase. Science 257: 1958-1961
32. Weinberg RA 1995 The retinoblastoma protein and cell cycle control. Cell 81: 323-330
33. Riley DJ, Lee EY-H P, Lee W-H 1994 The retinoblastoma protein: More than a tumor suppressor. Annu Rev Cell Biol 10: 1-29
34. Wakeling AE, Dukes M, Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867-3873
35. Howell A, DeFriend D, Robertson J, Blarney R, Walton P 1995 Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer. Lancet 345: 29-30
36. Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA, Sutherland RL 1993 Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133
37. Philipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M 1994 Repression of cyclin D1: A novel function of MYC. Mol Cell Biol 14: 4032-4043
38. Daksis JI, Lu RY, Facchini LM, Marhin WW, Penn LJ 1994 Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9: 3635-3645
39. Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G, Eilers M 1993 Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA 90: 3685-3689
40. Amati B, Land H 1994 Myc-Max-Mad: A transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev 4: 102-108
41. Dubik D, Dembinski TC, Shiu RPC 1987 Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res 47: 6517-6521
42. Watson PH, Pon RT, Shiu RPC 1991 Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res 51: 3996-4000
43. Wilcken NRC, Sarcevic B, Musgrove EA, Sutherland RL 1995 Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Cell Growth Differ, in press
44. Serrano M, Hannon GJ, Beach D 1993 A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707
45. Xu L, Sgroi D, Sterner CJ, Beauchamp RL, Pinney DM, Keel S, Ueki K, Rutter JL, Buckler AJ, Louis DN, Gusella JF, Ramesh V 1994 Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. Cancer Res 54: 5262-5264
46. Polyak K, Kato J-Y, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A 1994 P27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22
47. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ 1993 The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
48. Kato J-Y, Matsuoka M, Polyak K, Massague J, Sherr CJ 1994 Cyclic AMP-induced G, phase arrest mediated by an inhibitor (p27KIP1) of cyclin-dependent kinase 4 activation. Cell 79: 487-496
49. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA 1994 Mechanisms of regulation of WAF1/ CIP1 gene expression in human breast carcinoma: Role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407-3415
50. Cocks BG, Viaro G, Bodrug SE, Hamilton JA 1992 Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J Biol Chem 267: 12307-12310
51. Reddel RR, Murphy LC, Hall RE, Sutherland RL 1985 Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res 45: 1525-1531
52. Thompson EW, Katz D, Shima TB, Wakeling AE, Lipp-man ME, Dickson RB 1989 ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Cancer Res 49: 6929-6934
53. Alexander IE, Clarke CL, Shine J, Sutherland RL 1989 Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Mol Endocrinol 3: 1377-1386
54. Musgrove EA, Lee CSL, Sutherland RL 1991 Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor a, epidermal growth factor receptor, c-fos and c-myc genes. Mol Cell Biol 11: 5032-5043
55. Xiong Y, Connolly T, Futcher B, Beach D 1991 Human D-type cyclin. Cell 65: 691-699
56. Pines J, Hunter T 1990 Human cyclin A is adenovirus E1 A-associated protein p60 and behaves differently from cyclin B. Nature 346: 760-763
57. Hanks SK 1987 Homology probing: Identification of cDNA clones encoding members of the protein-serine kinase family. Proc Natl Acad Sci USA 84: 388-392
58. Chan Y-L, Gutell R, Noller HF, Wool IG 1984 The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid. J Biol Chem 259: 224-230
59. Kaelin WG, Pallas DC, DeCaprio JA, Kaye FJ, Livingston DM 1991 Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64: 521-532
60. Musgrove EA, Sarcevic B, Sutherland RL 1995 Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for CDK2 activation and pRB hyperphosphorylation. J Cell Biochem, in press
61. Bartkova J, Lukas J, Strauss M, Bartek J 1994 Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 172: 237-245